Prospective trial of intraoperative radiation treatment for breast cancer

ANZ Journal of Surgery

Volumn 74, Issue 12, 2004, Pages 1043-1048

  Joseph, David J ^a   Bydder, Sean ^a,b   Jackson, Lee R ^b   Corica, Tammy ^a   Hastrich, Diana J ^a   Oliver, David J ^a   Minchin, David E ^a   Haworth, Annette ^a   Saunders, Christobel M ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breast cancer; Intraoperative procedures; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATITIS; FEMALE; HUMAN; LUNG TOXICITY; MASTITIS; OPERATION DURATION; PEROPERATIVE CARE; PROSPECTIVE STUDY; PRURITUS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECURRENCE RISK; SKIN TOXICITY; SUBCUTANEOUS TISSUE;

ADULT; AGED; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE CARE; MASTECTOMY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 10844290687     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-1433.2004.03264.x     Document Type: Article

References (47)

1. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 1995; 333: 1456-61.
2. Veronesi U, Cascinelli N, Mariani L et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N. Engl. J. Med. 2002;347:1227-32.
3. Sarrazin D, Le MG, Arriagada R et al. Ten year results of a randomized trial comparing a conservative treatment and mastectomy in early breast cancer. Radiother. Oncol. 1989; 14: 177-84.
4. van Dongen JA, Voogd AC, Fentiman IS et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J. Natl Cancer Inst. 2000; 92: 1143-50.
5. Blichert-Toft M, Rose C, Andersen JA et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life analysis. J. Natl Cancer Inst. Monogr. 1992; 11: 19-26.
6. Liljegren G, Holmberg L, Bergh J et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J. Clin. Oncol. 1999; 17: 2326-33.
7. Clark RM, Whelan T, Levine M et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer; an update. J. Natl Cancer Inst. 1996; 88: 1659-64.
8. Forrest AP, Stewart HJ, Everington D et al. Randomised controlled trial of conservative therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 1996; 348: 708-13.
9. Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R. The importance of the resection margin in conservative surgery for breast cancer. Eur. J. Surg. Oncol. 1996; 22: 17-22.
10. Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann. Oncol. 2001; 12: 997-1003.
11. Douglas RM, Beatty J, Gall K et al. Dosimetric results from a feasibility study of a novel radiosurgical source for irradiation of intracranial metastases. Int. J. Radiat. Oncol. Biol. Phys. 1996; 36: 443-50.
12. Beatty J, Biggs PJ, Gall K et al. A new miniature x-ray device for interstitial radiosurgery: dosimetry. Med. Phys. 1996; 23: 53-62.
13. Hakim R, Zervas NT, Hakim F et al. Initial characterization of the dosimetry and radiology of a device for administering interstitial stereotactic radiosurgery. Neurosurgery 1997; 40: 510-16.
14. Cosgrove GR, Hochberg FH, Zervas NT, Pardo FS, Valenzuela RF, Chapman P. Interstitial irradiation of brain tumors, using a miniature radiosurgery device: initial experience. Neurosurgery 1997; 40: 518-23.
15. Brenner DJ, Leu CS, Beatty JF, Shefer RE. Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices. Phys. Med. Biol. 1999; 44: 323-33.
16. Cosgrove R, Spiro I, Loeffler J, Biggs P, Beatty J, Zervas NT. Stereotactic interstitial radiosurgery for malignant brain tumors. Stereotact. Funct. Neurosurg. 1999; 73: 37.
17. Ebert MA, Carruthers B. Dosimetric characteristics of a low-kV intra-operative x-ray source: implications for use in a clinical trial for treatment of low-risk breast cancer. Med. Phys. 2003; 30: 2424-31.
18. Vaidya JS, Baum M, Tobias JS et al. Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann. Oncol. 2001; 12: 1075-80.
19. Vaidya JS, Hall-Craggs M, Baum M et al. Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. Lancet Oncol. 2002; 3: 252-3.
20. Vaidya JS, Baum M, Tobias JS, Morgan S, D'Souza D. The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur. J. Surg. Oncol. 2002; 28: 447-54.
21. Cancer Therapy Evaluation Program. Common Toxicity Criteria, Version 2.0. Division of Cancer Treatment and Diagnosis. Bethesda: National Cancer Institute, National Institutes of Health, Department of Health & Human Services, 1999.
22. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 1995; 31: 1341-6.
23. Platt R, Zaleznik DF, Hopkins CC et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N. Engl. J. Med. 1990; 322: 153-60.
24. Rotstein C, Ferguson R, Cummings KM, Piedmonte MR, Lucey J, Banish A. Determinants of clean surgical wound infections for breast procedures at an oncology center. Infect. Control Hosp. Epidemiol. 1992; 13: 207-14.
25. Gupta R, Sinnett D, Carpenter R, Preece PE, Royle GT. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur. J. Surg. Oncol. 2000; 26: 363-6.
26. Sorensen LT, Horby J, Friis E, Pilsgaard B, Jorgensen T. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur. J. Surg. Oncol. 2002; 28: 815-20.
27. Witt A, Yavuz D, Walchetseder C, Strohmer H, Kubista E. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet. Gynecol. 2003; 101: 745-50.
28. Reid R, Simcock JW, Chisholm L, Dobbs B, Frizelle FA. Postdischarge clean wound infections: incidence underestimated and risk factors overemphasized. ANZ J. Surg. 2002; 72: 339-43.
29. Rescigno J, McCormick B, Brown AE, Myskowski PL. Breast cellulitis after conservative surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1994; 29: 163-8.
30. Staren ED, Klepac S, Smith AP et al. The dilemma of delayed cellulitis after breast conservation therapy. Arch. Surg. 1996; 131: 651-4.
31. Hughes LL, Styblo TM, Thoms WW et al. Cellulitis of the breast as a complication of breast-conserving surgery and irradiation. Am. J. Clin. Oncol. 1997; 20: 338-41.
32. Mertz KR, Baddour LM, Bell JL, Gwin JL. Breast cellulitis following breast conservation therapy: a novel complication of medical progress. Clin. Infect. Dis. 1998; 26: 481-6.
33. Miller SR, Mondry T, Reed JS, Findley A, Johnstone PA. Delayed cellulitis associated with conservative therapy for breast cancer. J. Surg. Oncol. 1998; 67: 242-5.
34. Baddour LM. Breast cellulitis complicating breast conservation therapy. J. Intern. Med. 1999; 245: 5-9.
35. Brewer VH, Hahn KA, Rohrbach BW, Bell JL, Baddour LM. Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clin. Infect. Dis. 2000; 31: 654-9.
36. Zippel D, Siegelmann-Danieli N, Ayalon S, Kaufman B, Pfeffer R, Zvi Papa M. Delayed breast cellulitis following breast conserving operation. Eur. J. Surg. Oncol. 2003; 29: 327-30.
37. Ribeiro GG, Magee B, Swindell R et al. The Christie Hospital Breast Conservation Trial: an update at 8 years from inception. Clin. Oncol. 1993; 5: 278-83.
38. Perera F, Engel J, Holliday R et al. Local resection and brachy-therapy confined to the lumpectomy site for early breast cancer: a pilot study. J. Surg. Oncol. 1997; 65: 263-7.
39. Vicini FA, Kini VR, Chen P et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J. Surg. Oncol. 1999; 70: 33-40.
40. Veronesi U, Orecchia R, Luini A et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur. J. Cancer 2001; 37: 2178-83.
41. Polgar C, Sulyok Z, Fodor J et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J. Surg. Oncol. 2002; 80: 121-8.
42. Intra M, Gatti G, Luini A et al. Surgical technique of intraoperative radiotherapy in conservative treatment of limited-stage breast cancer. Arch. Surg. 2002; 137: 737-40.
43. Vaidya JS, Tobias JS, Baum M et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 2004; 5: 165-73.
44. Muller-Runkel R, Vijayakumar S. Equivalent total doses for different fractionation schemes, based on the linear quadratic model. Radiology 1991; 179: 573-7.
45. Hopewell JW, Trott KR. Volume effects in radiobiology as applied to radiotherapy. Radiother. Oncol. 2000; 56: 283-8.
46. Wyatt RM, Beddoe AH, Dale RG. The effects of delays in radiotherapy treatment on tumour control. Phys. Med. Biol. 2003; 48: 139-55.
47. Kirkpatrick JP, Marks LB. Modeling killing and repopulation kinetics of subclinical cancer: direct calculations from clinical data. Int. J. Radiat. Oncol. Biol. Phys. 2004; 58: 641-54.